In Situ versus Systemic Immune Response in the Pathogenesis of Cutaneous Leishmaniasis

Augusto M Carvalho1,2,3, Rúbia S Costa1,2, Alexsandro Lago2

  • 1Gonçalo Moniz Institute (IGM), Fiocruz, Salvador 40296-710, BA, Brazil.

PubMed

Insights

Cytokine profiles in peripheral blood mononuclear cells (PBMCs) do not fully mirror the immune response at cutaneous leishmaniasis (CL) lesion sites. This study highlights distinct immune cell activities in CL patients, impacting disease pathology.

Area of Science:

  • Immunology
  • Infectious Diseases

Background:

  • Cutaneous leishmaniasis (CL) pathogenesis involves immune responses, primarily mediated by blood cells.
  • Understanding the correlation between systemic and local immune responses in CL is crucial for effective treatment.

Purpose of the Study:

  • To investigate whether cytokine production by peripheral blood mononuclear cells (PBMCs) in CL patients reflects the immune environment at the lesion site.
  • To identify key cytokines and their correlations with disease severity.

Main Methods:

  • Peripheral blood mononuclear cells (PBMCs) and lesion biopsies from 22 CL patients were stimulated with soluble leishmania antigen (SLA).
  • Cytokine levels (TNF, IL-1β, IL-6, IL-17, GzmB, IFN-γ, IL-10) were measured using ELISA.
  • Correlations between cytokine levels, lesion size, and patient data were analyzed.

Main Results:

  • Cytokine levels for TNF, IL-1β, IL-6, IL-17, and granzyme B (GzmB) were significantly higher in lesion biopsies compared to PBMCs.
  • Interferon-gamma (IFN-γ) was higher in PBMCs than in biopsies.
  • IL-1β, IL-17, and GzmB showed a strong correlation with lesion size, suggesting their role in CL pathology.

Conclusions:

  • The immune response at the CL lesion site differs from that observed in peripheral blood.
  • IL-17, in addition to IL-1β and GzmB, plays a significant role in the pathology of CL caused by *Leishmania (Viannia) braziliensis*.